The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Epidermal growth factor receptor mutation (EGFRMUT) in non-small cell lung cancer (NSCLC) in the Middle East.
Abdul Rahman Jazieh
Consultant or Advisory Role - Clarient
Honoraria - Roche
Research Funding - AstraZeneca; Roche
Hassan Nadim Jaafar
No relevant relationships to disclose
Rasha Mustafa
No relevant relationships to disclose
Kakil Rasul
No relevant relationships to disclose
Jamal Zekri
No relevant relationships to disclose
Rabab Mohamed Gaafar
No relevant relationships to disclose
Hamed Homoud Al Husaini
No relevant relationships to disclose
Hamdy A. Azim
No relevant relationships to disclose
Hanaa Bamefleh
No relevant relationships to disclose
Ahmed Gasmelseed
No relevant relationships to disclose